Mechanisms of Ultrasound Neuromodulation Effects in Diabetes
NCT: NCT06042517 · RECRUITING
NCT IDNCT06042517
StatusRECRUITING
Start Date2023-09-30
Completion2027-09-30
SponsorYale University (OTHER)
First posted
Last updated
Brief Summary
This study aims to evaluate the effect of hepatic ultrasound treatment on changes from baseline in whole-body insulin sensitivity during a hyperinsulinemic, euglycemic clamp (HE Clamp).
Frequently Asked Questions
What is Mechanisms of Ultrasound Neuromodulation Effects in Diabetes?
Mechanisms of Ultrasound Neuromodulation Effects in Diabetes is a clinical trial registered under NCT06042517. Current status: RECRUITING.
What is the status of NCT06042517?
The current status of NCT06042517 (Mechanisms of Ultrasound Neuromodulation Effects in Diabetes) is: RECRUITING.
When did Mechanisms of Ultrasound Neuromodulation Effects in Diabetes start?
Mechanisms of Ultrasound Neuromodulation Effects in Diabetes started on 2023-09-30.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.